Try our Advanced Search for more refined results

Deals Rumor Mill: Novartis, Siemens, Blackstone

By Karlee Weinmann ( December 10, 2013, 11:56 AM EST) -- Novartis AG is feeling out options for its animal health business, including a potential one-for-one swap for a yet-unnamed division of New Jersey-based Merck & Co. Inc., according to a Tuesday report from Bloomberg. The Swiss drugmaker is not looking to deepen its cash reserves but would like to beef up its assets in a market where it has an existing presence, such as over-the-counter treatments, where Merck has a toehold. Aside from Merck, the animal health business, valued at $4 billion including debt, has also drawn interest from German pharmaceutical supplier Boehringer Ingelheim GmbH, as well as Eli Lilly & Co. and Bayer AG....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!